Investor Centre

Welcome to ZOONO®'s Investor Centre, where you can engage with our mission to pioneer the global market with our superior, long-lasting antimicrobial products. Our commitment to innovation drives us to deliver shareholder value and a competitive edge in health and safety solutions.

ZOONO GROUP LIMITED

Specialising in the development,  manufacture and global distribution of  a suite of unique, highly effective, long-lasting antibacterial products that have a distinct competitive advantage.

ZOONO Group has developed (and owns) a wealth of Intellectual Property based around the “ZOONO® Molecule” – it’s a unique antibacterial molecule that bonds to any surface (including hard surfaces, textiles, fabrics, skin etc) and kills a range of pathogens. Best of all, it has proven efficacy and longevity – it does not leach and cannot diminish in strength. Today, ZOONO Group has established a global network of customers and distributors spread across many countries and territories. As the market leader in its field, ZOONO Group continues to develop new products and industry applications via a strong base of scientific, technical and training support.

Base.png__PID:700170e1-94e4-495c-8353-ca2558227691

SHARE PRICE

ZOONO Group Limited is listed on the Australian Stock Exchange.

ASX Listing: ZNO

Visit the ASX to view ZOONO® share prices. Prices may be delayed by 20 minutes. ASX user and terms and conditions apply.

Visit ASX: ZOONO®

SHAREHOLDER COMMUNICATIONS

Zoono is focused on reducing its carbon footprintwhilst providing you with timely corporate updates and disclosures.

BOARDROOMLIMITED.COM.AU

Recent legislative changes to the Corporations Act 2001 (Cth) mean there are new options for how Zoono shareholders receive communications. Zoono will no longer send physical meeting documents unless a shareholder requests a copy to be mailed.

Electronic communication has the added advantage of being timelier and more cost effective, which benefits all shareholders, and Zoono encourages all shareholders to provide an email address so we can communicate with you electronically when shareholder notices become available online, for items such as meeting documents, dividend statements and annual reports. You can make a standing election to receive some or all of your shareholder communications in physical or electronic form.

To review or update your current communication preference simply log on to our share registry’s website at https://www.investorserve.com.au/. You will need your log-in details or your Shareholder Reference Number (SRN) or Holder Identification Number (HIN) and select Communications Options from the menu on the left of the page tab.

If at any time you require an additional copy of the communication, or you need more information about the options available to you, please contact Boardroom Pty Limited via email at enquiries@boardroomlimited.com.au or contact the Registry at: Boardroom Pty Limited, GPO Box 3993, Sydney NSW 2001 Shareholders can use Boardroom InvestorServe to:
   - Set up and add their holdings to a portfolio
   - Review and update their contact details, communication       preferences and payment instructions
   - Provide their TFN and/or ABN
   - View their holding details
   - Make online enquiries
You will need your Security Reference Number (SRN) or Holder Identification Number (HIN) to verify your identity.

BookOpenText.png__PID:c6fa5e06-35a9-4788-a61f-5e245bead69b

Prospectus

Zoono Group Limited (ACN 006 645 754) (Zoono or the Company) is undertaking a non-renounceable rights issue of 1 Share for every 4 Shares held by those Shareholders registered at the Record Date at an issue price of $0.05 per Share together with 1 free New Options for every 3 Shares applied for and issued to raise up to $2,102,289. Shareholders also have the opportunity to apply for any securities not applied for under the Rights Issue.

Please download the below Entitlement Issue Prospectus for further details.

Personalised Entitlement and Acceptance Forms can be accessed at https://www.investorserve.com.au/.
The Offer closes at 5:00pm (AEDT) on Friday, 26 May 2023.

All Directors and Officers of the Company, including the Company’s largest shareholder, Managing Director, Paul Hyslop, will be taking up their full entitlements.

Revised Indicative Timetable
1. The revised timetable for the Rights Issue is set out below:
2. Lodgement of Prospectus with the ASIC 26 April 2023
3. Lodgement of Prospectus and Appendix 3B with ASX 26 April 2023
4. Ex date 1 May 2023
5. Record Date for determining Entitlements 2 May 2023
6. Offer opening date, Prospectus sent out to Shareholders and
7. Company announces this has been completed 5 May 2023
8. Last day to extend the Closing Date 23 May 2023
9. Closing Date as at 5:00pm* 26 May 2023
10. Shares quoted on a deferred settlement basis 29 May 2023
11. ASX notified of under subscriptions 2 June 2023
12. Issue date and lodgement of Appendix 2A with ASX applying for quotation of the Shares 2 June 2023
13. Quotation of Shares issued under the Offer** 5 June 2023

*The Directors may extend the Closing Date by giving at least three (3) Business Days’ notice to ASX prior to the Closing Date. Accordingly, the date the Securities are expected to commence trading on ASX may vary.

DownloadSimple.png__PID:4979d09d-0af1-4c45-abee-b9a9249f3a7c

Download Prospectus 

Prospectus (2).png__PID:105b77cf-c9fe-44e1-915e-6919714a59bd
Prospectus (3).png__PID:77cfc9fe-94e1-415e-a919-714a59bdb669

Important Documents

Corporate Governance 2024
Annual Report 2024
Interim Report 2023
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2021
Annual Report 2019

Zoono Agenda

Shareholder Dates

Key dates for 2023 financial results and shareholder meeting are as follows:

Financial Year End: 30 June 2023
Full Year Results Announcement: 24 August 2023

Last date to receive director nominations: 9 October 2023

Annual General Meeting: 27 November 2023.

Annual General Meetings

The 2023 Annual General Meeting of ZOONO® Group Limited will be held on Monday, 27th November 2023.

View the 2023 Notice of Meeting

View the 2023 Letter to Shareholders

View the 2023 Annual Report

Shareholder Dates

Key dates for 2023 financial results and shareholder meeting are as follows:

Financial Year End: 30 June 2023
Full Year Results Announcement: 24 August 2023

Last date to receive director nominations: 9 October 2023

Annual General Meeting: 27 November 2023

MANAGEMENT

Board of Directors

paul-hyslopjpg__PID:0f9ccd2d-3363-4a01-97e4-7b30908ccfc1

Paul Hyslop

MANAGING DIRECTOR / CEO

donjpg__PID:cd2d3363-0a01-47e4-bb30-908ccfc19d74

Don Clarke

NON-EXECUTIVE DIRECTOR

elissajpg__PID:33630a01-57e4-4b30-908c-cfc19d7489dd

Elissa Hansen

DIRECTOR/ COMPANY SECRETARY

POLICIES + CHARTERS

Corporate Governance

The Board of Directors is committed to maintaining high standards of Corporate Governance.
Please find below links to the Company’s Corporate Governance Policies and Charters.

Report (2).png__PID:e80be68e-5edc-4d70-b9ac-c81910cb6c5c
Report (3).png__PID:0be68e5e-dced-4039-acc8-1910cb6c5cc9
Report (4).png__PID:e68e5edc-ed70-49ac-8819-10cb6c5cc9a5
Report (5).png__PID:8e5edced-7039-4cc8-9910-cb6c5cc9a587
Report (6).png__PID:5edced70-39ac-4819-90cb-6c5cc9a587ed
Report (7).png__PID:dced7039-acc8-4910-8b6c-5cc9a587ed3b
Report (8).png__PID:ed7039ac-c819-40cb-ac5c-c9a587ed3b98
Report (9).png__PID:7039acc8-1910-4b6c-9cc9-a587ed3b987b
Report (11).png__PID:acc81910-cb6c-4cc9-a587-ed3b987b52b0
market-disclosure__PID:3815821e-28f6-4052-910f-4a15b2d806de
Report (12).png__PID:c81910cb-6c5c-49a5-87ed-3b987b52b0c4
Report (13).png__PID:1910cb6c-5cc9-4587-ad3b-987b52b0c4cd